Skip to main content
S&P 5007,688.62+1.58%DOW53,356.12+3.03%NASDAQ25,736.51+1.44%BTC$80,214.00+3.11%ETH$2,417.68+5.50%GOLD$4,068.50+3.25%OIL$88.12-8.29%
Smart Investors Daily
SID Premium
VV

NASDAQ · VVOS

Vivos Therapeutics, Inc.

Healthcare · Medical - Devices

$0.11

Up+$0.00 (+1.28%)

Updated Nov 4, 2026, 9:41 PM

SID Score

2.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
12.54M
P/E ratio
-1.37
Dividend yield
0.00%
52-week range
$0.11 – $1.54
Volume
442.55K
Avg. volume
279.52K

Price performance · VVOS

VVOS price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 3, 2026

VVOS closed at $0.11 after 21 trading sessions, down 28.56% for the selected period.

Last close
$0.11
Period change
-28.56%
Period low
$0.11
Period high
$0.15
Daily close
View OHLC price history
VVOS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 3, 2026$0.1091$0.1127$0.1059$0.1098442.55K
Nov 2, 2026$0.114$0.1192$0.1081$0.1083617.18K
Oct 30, 2026$0.115$0.1191$0.111$0.1138741.95K
Oct 29, 2026$0.1182$0.124$0.1145$0.12061.25M
Oct 28, 2026$0.1291$0.1291$0.1183$0.1219828.81K
Oct 27, 2026$0.1287$0.1289$0.1205$0.1283923.79K
Oct 26, 2026$0.1297$0.1314$0.1226$0.1313666.34K
Oct 23, 2026$0.1285$0.1345$0.125$0.1337936.32K
Oct 22, 2026$0.1241$0.1325$0.1241$0.13251.93M
Oct 21, 2026$0.1421$0.1447$0.1318$0.13474.72M
Oct 20, 2026$0.1307$0.1446$0.124$0.140676.7M
Oct 19, 2026$0.135$0.135$0.1248$0.134947.33M
Oct 16, 2026$0.1427$0.1427$0.1278$0.13111.62M
Oct 15, 2026$0.1348$0.15$0.1276$0.142811.62M
Oct 14, 2026$0.138$0.1454$0.134$0.134672.22K
Oct 13, 2026$0.1456$0.1456$0.1356$0.1416736.62K
Oct 12, 2026$0.1501$0.1501$0.14$0.1442491.55K
Oct 9, 2026$0.15$0.1599$0.144$0.14898.83M
Oct 8, 2026$0.151$0.1536$0.146$0.14951.98M
Oct 7, 2026$0.154$0.157$0.1454$0.151419.75K
Oct 6, 2026$0.154$0.1599$0.151$0.1537573.01K

Latest VVOS news

The latest Smart Investors Daily articles mentioning VVOS.

Stock researchCompany · Overview

VVOS research

Overview

Company profile and research snapshot.

Company profile

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$2.25
Implied upside
—
Analysts
—
VVOS recent ratings
DateFirmRatingTarget
Jun 4, 2026Ascendiant CapitalBuy—
Apr 22, 2026Ascendiant CapitalBuy—
Apr 17, 2026HC Wainwright & Co.Buy—
Dec 3, 2025Ascendiant CapitalBuy—
Nov 17, 2025HC Wainwright & Co.Buy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Aug 25, 2026

Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers

Average Weekly New Patient Referrals into Vivos’ Nevada Sleep & Airway Medicine Centers Rose 212% Over the Past Six Weeks from the Prior Six WeeksLITTLETON, Colo., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the Company”) (Nasdaq: VVOS), a leading medical device and healthcare services company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from obstructive sleep apnea (“OSA”) and other sleep disorders, t

Yahoo · Aug 20, 2026

Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment

New Location Expected to More Than Double Annual Revenue Production Capacity to Over $10 Million Official Grand Opening Slated for August 27 in Henderson, Nevada With Prominent Industry Opinion Leaders, Sleep Physicians, Dentists Among Scheduled Attendees LITTLETON, Colo., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the Company”) (Nasdaq: VVOS), a leading medical device and healthcare services company focused on developing and commercializing innovative diagnostic and

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By